These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 37442821)
1. Meta-analysis of the results of haploidentical transplantation in the treatment of aplastic anemia. Zhao J; Ma L; Zheng M; Su L; Guo X Ann Hematol; 2023 Sep; 102(9):2565-2587. PubMed ID: 37442821 [TBL] [Abstract][Full Text] [Related]
2. Comparison of frontline treatment with intensive immunosuppression therapy and HLA-haploidentical hematopoietic stem cell transplantation for young patients with severe aplastic anemia - A meta analysis. Geng C; Liu X; Chen M; Yang C; Han B Leuk Res; 2020 Jan; 88():106266. PubMed ID: 31743865 [TBL] [Abstract][Full Text] [Related]
3. Comparison of upfront haploidentical hematopoietic stem cell transplantation and salvage haploidentical hematopoietic stem cell transplantation after immunosuppressive therapy in children with acquired severe aplastic anemia - a multicenter study. Luo D; Qu Y; Wang D; Zhang B; Sun M; Xiong H; Lu J; Yang R; Zhao M; Liu H; Jiang H Front Immunol; 2024; 15():1384640. PubMed ID: 38720904 [TBL] [Abstract][Full Text] [Related]
4. Comparison of Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide versus Umbilical Cord Blood Transplantation in Adult Patients with Aplastic Anemia. Onishi Y; Mori T; Yamazaki H; Hiramoto N; Zaimoku Y; Kanaya M; Matsue K; Onizuka M; Aotsuka N; Uchida N; Onodera K; Kanda J; Nakamae H; Yamamoto R; Kuriyama T; Kimura T; Ichinohe T; Atsuta Y; Transplant Cell Ther; 2023 Dec; 29(12):766.e1-766.e8. PubMed ID: 37730121 [TBL] [Abstract][Full Text] [Related]
5. Comparison of Hematopoietic Stem Cell Transplantation Outcomes Using Matched Sibling Donors, Haploidentical Donors, and Immunosuppressive Therapy for Patients With Acquired Aplastic Anemia. Zhang Y; Huo J; Liu L; Shen Y; Chen J; Zhang T; Chen X; Pang A; Yang D; Zhang R; Ma Q; Zhai W; He Y; Wei J; Jiang E; Han M; Zheng Y; Feng S Front Immunol; 2022; 13():837335. PubMed ID: 35178053 [TBL] [Abstract][Full Text] [Related]
6. [Efficacy and safety of allogeneic hematopoietic stem cell transplantation in the treatment of 28 patients with hepatitis-related aplastic anemia]. Wang Y; Li J; Pang AM; Yang DL; Chen X; Zhang RL; Wei JL; Ma QL; Zhai WH; He Y; Jiang EL; Han MZ; Feng SZ Zhonghua Xue Ye Xue Za Zhi; 2023 Aug; 44(8):628-634. PubMed ID: 37803835 [No Abstract] [Full Text] [Related]
7. Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation Achieved Outcomes Comparable With Matched Unrelated Donor Transplantation in Young Acquired Severe Aplastic Anemia. Lu Y; Sun RJ; Zhao YL; Xiong M; Cao XY; Zhang JP; Wei ZJ; Zhou JR; Liu DY; Lu DP Biol Blood Marrow Transplant; 2018 Sep; 24(9):1881-1887. PubMed ID: 29772350 [TBL] [Abstract][Full Text] [Related]
8. Comparison of Outcomes of Frontline Immunosuppressive Therapy and Frontline Haploidentical Hematopoietic Stem Cell Transplantation for Children with Severe Aplastic Anemia Who Lack an HLA-Matched Sibling Donor. Yang S; Yuan X; Ma R; Jiang L; Guo J; Zang Y; Shi J; Yang J; Lei P; Liu Z; Zhang Y; Zhu Z Biol Blood Marrow Transplant; 2019 May; 25(5):975-980. PubMed ID: 30658223 [TBL] [Abstract][Full Text] [Related]
9. Hematopoietic stem cell transplantation without in vivo T-cell depletion for pediatric aplastic anemia: A single-center experience. Li S; Wang B; Fu L; Pang Y; Zhu G; Zhou X; Ma J; Su Y; Qin M; Wu R Pediatr Transplant; 2018 Aug; 22(5):e13204. PubMed ID: 29744996 [TBL] [Abstract][Full Text] [Related]
10. Outcome of Haploidentical Peripheral Blood Allografts Using Post-Transplantation Cyclophosphamide Compared to Matched Sibling and Unrelated Donor Bone Marrow Allografts in Pediatric Patients with Hematologic Malignancies: A Single-Center Analysis. Srinivasan A; Raffa E; Wall DA; Schechter T; Ali M; Chopra Y; Kung R; Chiang KY; Krueger J Transplant Cell Ther; 2022 Mar; 28(3):158.e1-158.e9. PubMed ID: 34838785 [TBL] [Abstract][Full Text] [Related]
11. Prospective Study of a Modified Post-Transplantation Cyclophosphamide Regimen for Severe Aplastic Anemia Patients with HLA-Haploidentical Transplantation. Wu L; Zhou M; Li Y; Chen X; Mo W; Wang C; Xu S; Zhou W; Deng T; Zhou R; Pan S; Wang S; Zhang Y Transplant Cell Ther; 2023 Jul; 29(7):463.e1-463.e7. PubMed ID: 37098408 [TBL] [Abstract][Full Text] [Related]
12. Comparison of efficacy and health-related quality of life of first-line haploidentical hematopoietic stem cell transplantation with unrelated cord blood infusion and first-line immunosuppressive therapy for acquired severe aplastic anemia. Liu L; Zhang Y; Jiao W; Zhou H; Wang Q; Jin S; Cai Y; Zhao L; Shangguan X; Liu Z; Xu J; Lei M; Yan X; Miao M; Wu D Leukemia; 2020 Dec; 34(12):3359-3369. PubMed ID: 32591644 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic Outcomes of Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Severe Aplastic Anemia: A Multicenter Study. Li Y; Duan F; Xiao H; Wu X; Wang S; Xu D; Liu Q; Fan Z; Nie D; Lai Y; Wu B; Lin D; Du X; Weng J; Jiang Z; Pang Y; Ouyang L; Liu Z; Zhang L; Han N; Chen L; Xiao Y Transplantation; 2018 Oct; 102(10):1724-1731. PubMed ID: 29677078 [TBL] [Abstract][Full Text] [Related]
14. Haploidentical stem cell transplantation vs matched unrelated donor transplantation in adults with hematologic malignancies: a systematic review and meta-analysis. Ma L; Han X; Jiang S; Meng Q; Zhang L; Bao H Hematology; 2020 Dec; 25(1):356-365. PubMed ID: 33054609 [TBL] [Abstract][Full Text] [Related]
15. Differences in Graft-versus-Host Disease Characteristics between Haploidentical Transplantation Using Post-Transplantation Cyclophosphamide and Matched Unrelated Donor Transplantation Using Calcineurin Inhibitors. Solh MM; Baron J; Zhang X; Bashey A; Morris LE; Holland HK; Solomon SR Biol Blood Marrow Transplant; 2020 Nov; 26(11):2082-2088. PubMed ID: 32745575 [TBL] [Abstract][Full Text] [Related]
16. First-line treatment of severe aplastic anemia: immunosuppressive therapy plus eltrombopag versus haploidentical hematopoietic stem cell transplantation, a multicenter prospective study. Liu L; Han B; Zhang Y; Lei M; Liu R; Lin Z; Jiao W; Zhang F; Fu R; Zhao X; Miao M; Zhang L; Wu D Bone Marrow Transplant; 2024 Oct; 59(10):1449-1457. PubMed ID: 39090437 [TBL] [Abstract][Full Text] [Related]
17. Outcomes of haploidentical peripheral stem cell transplantation with combination of post-transplant cyclophosphamide (PTCy) and anti-thymocyte globulin (ATG) compared to unrelated donor transplantation in acute myeloid leukemia: A retrospective 10-year experience. Barkhordar M; Kasaeian A; Janbabai G; Mousavi SA; Fumani HK; Tavakoli S; Bahri T; Ghavamzadeh A; Vaezi M Leuk Res; 2022 Sep; 120():106918. PubMed ID: 35843087 [TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stromal cells as prophylaxis for graft-versus-host disease in haplo-identical hematopoietic stem cell transplantation recipients with severe aplastic anemia?-a systematic review and meta-analysis. Li R; Tu J; Zhao J; Pan H; Fang L; Shi J Stem Cell Res Ther; 2021 Feb; 12(1):106. PubMed ID: 33541414 [TBL] [Abstract][Full Text] [Related]
19. [Comparison of Frontline Haploidentical Hematopoietic Stem Cell Transplantation and Salvage Haploidentical Hematopoietic Stem Cell Transplantation for Patients with Severe Aplastic Anemia]. Xiao F; Liu Q; Fan D; Guo HX; Yan XQ; Zhao H; Liu L Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1683-1688. PubMed ID: 33067974 [TBL] [Abstract][Full Text] [Related]
20. Comparison of Haploidentical Hematopoietic Stem Cell Transplant With or Without Unrelated Cord Blood Infusion in Severe Aplastic Anemia: Outcomes of a Multicenter Study. Lei M; Zhang Y; Jiao W; Li X; Zhou H; Wang Q; Qiu H; Tang X; Han Y; Fu C; Jin Z; Chen S; Sun A; Miao M; Liu L; Wu D Front Immunol; 2022; 13():912917. PubMed ID: 35812409 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]